The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior
This study enrolls adults ages 18-65 who have the symptoms of an ischemic stroke. An ischemic stroke is caused by a clot in a blood vessel that blocks blood flow to a certain part of the brain. The purpose of this study is to learn more about if people with this type of stroke do better when their blockage is removed within 24 hours of the stroke starting.
In this study you will either undergo usual medical care by itself or usual medical care and also have a clot removal procedure. You will be in this study for about three months after your stroke, including follow-up visits. Study takes place at Gates Vascular Institute, 875 Ellicott St, Buffalo NY 14203.
Compensation is not available.
Investigator-initiated phase III randomized controlled trial (RCT)
to establish the efficacy of intra-arterial (IA) mechanical thrombectomy in patients with acute ischemic stroke (AIS) from large vessel occlusion (LVO) in the anterior circulation and who have a moderate-large pretreatment infarct volume (Noncontrast
CT Alberta Stroke Program Early CT score (NCCT ASPECTS) 2-5.
Adults ages 18-65.
Presenting to the hospital with symptoms consistent with an acute ischemic stroke.
Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
Let us know how the study team can reach you.
If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email email@example.com and someone will assist you.